Company Filing History:
Years Active: 2017
Title: Seo Hyun Ahn: Innovator in Fatty Liver Disease Treatment
Introduction
Seo Hyun Ahn is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of fatty liver diseases. His innovative work has the potential to impact many lives suffering from liver-related health issues.
Latest Patents
Seo Hyun Ahn holds a patent for a composition aimed at preventing or treating fatty liver diseases. The patent describes a pharmaceutical composition that includes (tetrahydropyran-4-yl)-[2-phenyl-5-(1,1-dioxo-thiomorpholin-4-yl)methyl-1H-indol-7-yl]amine or a pharmaceutically acceptable salt thereof as active ingredients. This invention can effectively inhibit fatty liver, hepatitis, and hepatic fibrosis, making it useful for preventing or treating non-alcoholic fatty liver disease (NAFLD), particularly non-alcoholic steatohepatitis (NASH).
Career Highlights
Seo Hyun Ahn is currently associated with LG Chem, Ltd., a leading company in the chemical and pharmaceutical industry. His work at LG Chem has allowed him to focus on innovative solutions for health-related challenges.
Collaborations
Seo Hyun Ahn has collaborated with several talented individuals, including Soon Ha Kim and Hyoung Jin Kim. These collaborations have fostered a productive environment for research and development in the pharmaceutical sector.
Conclusion
Seo Hyun Ahn's contributions to the treatment of fatty liver diseases through his innovative patent highlight his role as a significant inventor in the pharmaceutical field. His work continues to pave the way for advancements in medical treatments.